Kristin Wynholds - Chief Product Officer at Better Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Product Officer
Stock Symbol
BTTX on Nasdaq
Industry
Services-Health Services
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kristin Wynholds since 7/4/2023

Holdings reported by Kristin Wynholds for Better Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 225,631 $38.3 K $0.17 Dec 18, 2023 Direct
Stock Option (Right to Buy) 101,450 Mar 1, 2023 Direct Common Stock

Transactions reported by Kristin Wynholds for Better Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership